We are currently conducting research into the potential use of Omnigen® (a dry preserved biological matrix, derived from human amnion) in the treatment of Diabetic Foot Ulcers (DFUs).
As part of this research we would like to gain a better understanding of the pathway for new products into this market. Please could you could spare 4 minutes of your time to complete a quick survey? If so, please click on the link below
Across international healthcare, artificial intelligence (AI) has transitioned from a novel innovation to a critical component in reshaping treatment approaches and patient care dynamics. As Managing Director of Pym's Consultancy, I've witnessed first-hand the...
As the managing director of Pym's Consultancy, I have closely followed the evolution of healthcare strategies and their implementations within the NHS. The NHS Mandate 2025, announced by Wes Streeting, Secretary of State for Health and Social Care, in January,...
Recent findings from a comprehensive review at Walsall Healthcare NHS Trust have cast a stark light on the consequences of clinical errors in medical practice. The report unveiled that 24% of the 382 cases reviewed were associated with moderate to severe harm to...